126 related articles for article (PubMed ID: 7192092)
1. [Basis of infusion solutions. III. Systematization and directions for the use of infusion solutions].
Schmitz JE; Ahnefeld FW
Beitr Infusionther Klin Ernahr; 1980; 5():29-47. PubMed ID: 7192092
[No Abstract] [Full Text] [Related]
2. [Summary of the discussion on the subject of: "technical problems in the production and use of infusion solutions"].
Klin Anasthesiol Intensivther; 1977; (14):95-105. PubMed ID: 926695
[No Abstract] [Full Text] [Related]
3. [Quality control of infusion solutions. I. Foreign particles in infusion solutions].
van den Bemd AA
Pharm Weekbl; 1969 Sep; 104(39):1205-9. PubMed ID: 5345140
[No Abstract] [Full Text] [Related]
4. [Basis of infusion therapy. II. Systematization and permits for infusion solutions].
Schmitz JE; Ahnefeld FW
Beitr Infusionther Klin Ernahr; 1980; 5():11-28. PubMed ID: 7192091
[No Abstract] [Full Text] [Related]
5. [Storage capabilities of individually prepared infusion solutions].
Bánhalmi Z; Korbély I; Kurucz T; Mohr T
Acta Pharm Hung; 1979 Jul; 49(4):145-59. PubMed ID: 474138
[No Abstract] [Full Text] [Related]
6. The compatibility and stability of midazolam and dexamethasone in infusion solutions.
Good PD; Schneider JJ; Ravenscroft PJ
J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775
[TBL] [Abstract][Full Text] [Related]
7. [Special problems in the development of modern infusion solutions].
Frank P
Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Mar; 40(3):77-88. PubMed ID: 5467832
[No Abstract] [Full Text] [Related]
8. [Basic rules for the production of infusion solutions and in the ensuring of their quality].
Ganshirt KH; Pauli W; Rössler R
Klin Anasthesiol Intensivther; 1977; (14):1-17. PubMed ID: 926675
[No Abstract] [Full Text] [Related]
9. [Bacterial content control and study of aseptic procedure in preparation of infusion solutions].
Bábik I; Sagáth J
Pharm Prax; 1968; 2():34-7. PubMed ID: 5731460
[No Abstract] [Full Text] [Related]
10. Particulate matter in parenteral solutions.
Med Lett Drugs Ther; 1968 May; 10(11):42-4. PubMed ID: 5656614
[No Abstract] [Full Text] [Related]
11. Parenteral formulation. VI. Hydrolytic degradation of esters in parenteral solutions.
Anschel J; Mollica JA; Lin KS
Bull Parenter Drug Assoc; 1972; 26(6):271-89. PubMed ID: 4629105
[No Abstract] [Full Text] [Related]
12. [Establishment of a center for the production of infusion solutions].
Grundmann W
Pharm Prax; 1973; 1():6-10. PubMed ID: 4714226
[No Abstract] [Full Text] [Related]
13. Implications of I V additive programs to the parenteral industry.
Latiolais CJ
Bull Parenter Drug Assoc; 1970; 24(1):45-51. PubMed ID: 5415612
[No Abstract] [Full Text] [Related]
14. [Problems with the infusion-solution application technic in internal medicine].
Gilfrich HJ; Schuster HP
Klin Anasthesiol Intensivther; 1977; (14):165-71. PubMed ID: 926682
[No Abstract] [Full Text] [Related]
15. [Types of infusion fluids and methods of their administration].
Hirata K
Kango Gijutsu; 1978 May; 24(7):19-30. PubMed ID: 248481
[No Abstract] [Full Text] [Related]
16. Bulk compounding technology.
Am J Hosp Pharm; 1968 Jun; 25(6):320. PubMed ID: 5656779
[No Abstract] [Full Text] [Related]
17. Preservative combinations: a microbiological assessment.
Wakely JH; Hall NC; Krezanoski JZ
Bull Parenter Drug Assoc; 1967; 21(4):124-35. PubMed ID: 6045458
[No Abstract] [Full Text] [Related]
18. Guidelines for phenytoin infusions.
Tuttle CB
Can J Hosp Pharm; 1984; 37(4):137-9. PubMed ID: 10269318
[TBL] [Abstract][Full Text] [Related]
19. [Classification of infusion therapy].
Schmitz JE
Klin Anasthesiol Intensivther; 1977; (14):89-94. PubMed ID: 926694
[No Abstract] [Full Text] [Related]
20. [Basis of infusion therapy. I. Systematizing and classification of solutions for infusion].
Schmitz JE; Ahnefeld FW
Beitr Infusionther Klin Ernahr; 1980; 5():1-10. PubMed ID: 7192090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
